Temat: "Use" - OpacWWW - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: Implementing a tobacco-free workplace program at a substance use treatment center: a case study.
Autorzy:: Rogova A; The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, 77230-1402, Houston, TX, Unit 1444, P.O. Box 301402, United States of America. .; University of Houston, 3657 Cullen Blvd, Stephen Power Farish Hall, 77204, Houston, TX, United States of America. .
Leal IM; The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, 77230-1402, Houston, TX, Unit 1444, P.O. Box 301402, United States of America.; University of Houston, 3657 Cullen Blvd, Stephen Power Farish Hall, 77204, Houston, TX, United States of America.
Britton M; The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, 77230-1402, Houston, TX, Unit 1444, P.O. Box 301402, United States of America.; University of Houston, 3657 Cullen Blvd, Stephen Power Farish Hall, 77204, Houston, TX, United States of America.
Chen TA; University of Houston, 3657 Cullen Blvd, Stephen Power Farish Hall, 77204, Houston, TX, United States of America.
Lowenstein LM; The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, 77230-1402, Houston, TX, Unit 1444, P.O. Box 301402, United States of America.
Kyburz B; Integral Care, 1430 Collier St, 78704, Austin, TX, United States of America.
Casey K; Integral Care, 1430 Collier St, 78704, Austin, TX, United States of America.
Skeene K; Integral Care, 1430 Collier St, 78704, Austin, TX, United States of America.
Williams T; Integral Care, 1430 Collier St, 78704, Austin, TX, United States of America.
Reitzel LR; The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, 77230-1402, Houston, TX, Unit 1444, P.O. Box 301402, United States of America.; University of Houston, 3657 Cullen Blvd, Stephen Power Farish Hall, 77204, Houston, TX, United States of America.; Pokaż więcej
Źródło:: BMC health services research [BMC Health Serv Res] 2024 Feb 14; Vol. 24 (1), pp. 201. Date of Electronic Publication: 2024 Feb 14.
Typ publikacji:: Journal Article
MeSH Terms:: Smoking Cessation*
Substance-Related Disorders*/therapy
Tobacco Use Cessation*
Humans ; United States ; Tobacco Use Cessation Devices ; Workplace

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Tobacco Product Use Among U.S. Middle and High School Students - National Youth Tobacco Survey, 2023.
Autorzy:: Birdsey J
Cornelius M
Jamal A
Park-Lee E
Cooper MR
Wang J
Sawdey MD
Cullen KA
Neff L; Pokaż więcej
Źródło:: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2023 Nov 03; Vol. 72 (44), pp. 1173-1182. Date of Electronic Publication: 2023 Nov 03.
Typ publikacji:: Journal Article
MeSH Terms:: Tobacco Use Disorder*
Electronic Nicotine Delivery Systems*
Tobacco Products*
United States/epidemiology ; Humans ; Adolescent ; Nicotine ; Health Surveys ; Cross-Sectional Studies ; Tobacco Use/epidemiology ; Students

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Tobacco exposure among antenatal women in India: Challenges in tobacco screening & cessation counselling.
Autorzy:: Chaudhary J; Division of Clinical Oncology, ICMR-National Institute of Cancer Prevention and Research, Noida, Uttar Pradesh, India.; ICMR-National Institute of Cancer Prevention and Research, Noida, Uttar Pradesh, India.
Gupta E; Division of Clinical Oncology, ICMR-National Institute of Cancer Prevention and Research, Noida, Uttar Pradesh, India.; ICMR-National Institute of Cancer Prevention and Research, Noida, Uttar Pradesh, India.
Singh PK; Division of Preventive Oncology & Population Health, ICMR-National Institute of Cancer Prevention and Research, Noida, Uttar Pradesh, India.
Singh S; Division of Clinical Oncology, ICMR-National Institute of Cancer Prevention and Research, Noida, Uttar Pradesh, India.; Pokaż więcej
Źródło:: The Indian journal of medical research [Indian J Med Res] 2023 Nov 01; Vol. 158 (5&6), pp. 477-482. Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:: Review; Journal Article
MeSH Terms:: Counseling*
Tobacco Use Cessation*
Female ; Humans ; Pregnancy ; India/epidemiology ; Tobacco Use

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Real-world treatment outcomes of medicines used in special situations (off-label and compassionate use) in oncology and hematology: A retrospective study from a comprehensive cancer institution.
Autorzy:: Fontanals S; Pharmacy Department, Catalan Institute of Oncology (ICO)-Hospitalet, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), School of Medicine, Universitat de Barcelona (UB), Barcelona, Spain.
Esteve A; Research Management Unit (Unitat de Gestió de la recerca: UGR), Medical Oncology Department, Catalan Institute of Oncology (ICO), Badalona-Applied Research Group in Oncology (B-ARGO), Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain.
González A; Medical Oncology Department, Catalan Institute of Oncology (ICO), Badalona-Applied Research Group in Oncology (B-ARGO) Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain.
Ibáñez C; Pharmacy Department, Catalan Institute of Oncology (ICO)-Hospitalet, School of Health Sciences, Blanquerna Ramon Llull University, Barcelona, Spain.
Martínez J; Pharmacy Department, Catalan Institute of Oncology (ICO)-Hospitalet, Barcelona, Spain.
Mesía R; Medical Oncology Department, Catalan Institute of Oncology (ICO), Badalona-Applied Research Group in Oncology (B-ARGO) Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain.
Clopés A; Pharmacy Department, Catalan Institute of Oncology (ICO)-Hospitalet, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), School of Health Sciences, Blanquerna Ramon Llull University, Barcelona, Spain.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Aug; Vol. 12 (16), pp. 17112-17125. Date of Electronic Publication: 2023 Jul 26.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Compassionate Use Trials*
Neoplasms*/drug therapy
Adult ; Humans ; Female ; Retrospective Studies ; Off-Label Use ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Real-world treatment outcomes of immune checkpoint inhibitors used off-label in oncology: A comprehensive cancer institution experience.
Autorzy:: Fontanals S; Pharmacy Department, Catalan Institute of Oncology (ICO)- Hospitalet, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), School of Medicine, Universitat de Barcelona (UB), ICO, Hospitalet de Llobregat, Barcelona, Spain.
Esteve A; Research Management Unit (UGR), Catalan Institute of Oncology (ICO), Medical Oncology Department, ICO-Badalona, Applied Research Group in Oncology (B-ARGO), Germans Trias I Pujol Research Institute (IGTP), ICO, Badalona, Spain.
González A; Medical Oncology Department, Catalan Institute of Oncology (ICO), Badalona-Applied Research Group in Oncology (B-ARGO) Germans Trias I Pujol Research Institute (IGTP), ICO, Badalona, Spain.
Ibáñez C; Pharmacy Department, Catalan Institute of Oncology (ICO)-Hospitalet, Blanquerna Ramon Llull University, School of Health Sciences, ICO, Hospitalet de Llobregat, Barcelona, Spain.
Mesía R; Medical Oncology Department, Catalan Institute of Oncology (ICO), Badalona-Applied Research Group in Oncology (B-ARGO) Germans Trias I Pujol Research Institute (IGTP), ICO, Badalona, Spain.
Clopés A; Pharmacy Department, Catalan Institute of Oncology (ICO)-Hospitalet, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), School of Health Sciences, Blanquerna Ramon Llull University, ICO, Hospitalet de Llobregat, Barcelona, Spain.; Pokaż więcej
Źródło:: Pharmacology research & perspectives [Pharmacol Res Perspect] 2024 Feb; Vol. 12 (1), pp. e1167.
Typ publikacji:: Journal Article
MeSH Terms:: Immune Checkpoint Inhibitors*/therapeutic use
Neoplasms*/drug therapy
Male ; Humans ; Female ; Middle Aged ; Off-Label Use ; Medical Oncology ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Smoking cessation through nicotine replacement therapy for patients visiting the Dental College, Pune - A quasi-experimental study.
Autorzy:: Mukadam A; Department of Public Health Dentistry, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, Maharashtra, India.
Shetiya SH; Department of Public Health Dentistry, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune, Maharashtra, India.; Pokaż więcej
Źródło:: Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Jul-Sep; Vol. 19 (5), pp. 1365-1370.
Typ publikacji:: Journal Article
MeSH Terms:: Smoking Cessation*/methods
Tobacco Use Disorder*/therapy
Humans ; Male ; Young Adult ; Adult ; Female ; Nicotine/adverse effects ; Cotinine ; Nicotinic Agonists ; Tobacco Use Cessation Devices ; India

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Tobacco Product Use Among Adults - United States, 2021.
Autorzy:: Cornelius ME
Loretan CG
Jamal A
Davis Lynn BC
Mayer M
Alcantara IC
Neff L; Pokaż więcej
Źródło:: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2023 May 05; Vol. 72 (18), pp. 475-483. Date of Electronic Publication: 2023 May 05.
Typ publikacji:: Journal Article
MeSH Terms:: Electronic Nicotine Delivery Systems*
Tobacco Use Disorder*/epidemiology
Tobacco Products*
Tobacco, Smokeless*
Cigarette Smoking*
Male ; Female ; Adult ; Humans ; United States/epidemiology ; Adolescent ; Socioeconomic Factors ; Health Surveys ; Tobacco Use/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Neurobiology of Stress-Induced Nicotine Relapse.
Autorzy:: Wang X; Institute of Brain Science and Advanced Technology, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Medicine, Wuhan University of Science and Technology, Wuhan 430065, China.
Chen Y; Institute of Brain Science and Advanced Technology, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Medicine, Wuhan University of Science and Technology, Wuhan 430065, China.
Dong J; Institute of Brain Science and Advanced Technology, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Medicine, Wuhan University of Science and Technology, Wuhan 430065, China.
Ge J; Institute of Brain Science and Advanced Technology, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Medicine, Wuhan University of Science and Technology, Wuhan 430065, China.
Liu X; Institute of Brain Science and Advanced Technology, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Medicine, Wuhan University of Science and Technology, Wuhan 430065, China.
Liu J; Institute of Brain Science and Advanced Technology, Hubei Province Key Laboratory of Occupational Hazard Identification and Control, School of Medicine, Wuhan University of Science and Technology, Wuhan 430065, China.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Jan 25; Vol. 25 (3). Date of Electronic Publication: 2024 Jan 25.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Tobacco Use Disorder*/drug therapy
Receptors, Nicotinic*
Humans ; Nicotine/therapeutic use ; Reward ; Corticotropin-Releasing Hormone/pharmacology ; Recurrence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Update to Gabapentinoid Use in the United States, 2002-2021.
Autorzy:: Johansen ME; Grant Family Medicine, OhioHealth, Columbus, Ohio .
Maust DT; Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan.; Department of Psychiatry, University of Michigan, Ann Arbor, Michigan.; Pokaż więcej
Źródło:: Annals of family medicine [Ann Fam Med] 2024 Jan-Feb; Vol. 22 (1), pp. 45-49.
Typ publikacji:: Journal Article
MeSH Terms:: Chronic Pain*/drug therapy
Gabapentin*/therapeutic use
Adult ; Humans ; United States ; Off-Label Use

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Longitudinal trajectories of marijuana use in tobacco products among young adult Texas college students from 2015 to 2019.
Autorzy:: Hinds JT; Steve Hicks School of Social Work, The University of Texas at Austin, Austin, TX, USA.
Marti CN; Department of Kinesiology and Health Education, The University of Texas at Austin, Austin, TX, USA.
Pasch KE; Department of Kinesiology and Health Education, The University of Texas at Austin, Austin, TX, USA.
Loukas A; Department of Kinesiology and Health Education, The University of Texas at Austin, Austin, TX, USA.; Pokaż więcej
Źródło:: Addiction (Abingdon, England) [Addiction] 2023 Feb; Vol. 118 (2), pp. 372-377. Date of Electronic Publication: 2022 Sep 14.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Marijuana Use*/epidemiology
Electronic Nicotine Delivery Systems*
Tobacco Products*
Cannabis*
Humans ; Young Adult ; Female ; Adult ; Child, Preschool ; Nicotiana ; Longitudinal Studies ; Texas/epidemiology ; Nicotine ; Tobacco Use/epidemiology ; Students

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Informacja:: Dostęp do tej pozycji wymaga zalogowania się.

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Long-term follow-up of tobacco cessation intervention in a dental setting: A randomized trial.
Autorzy:: Sujatha S; Department of Oral Medicine and Radiology, Faculty of Dental Sciences, Ramaiah University of Applied Sciences, Bengaluru, Karnataka, India.
Iyengar A; Department of Oral Medicine and Radiology, RV dental College and Hospital, Bengaluru, Karnataka, India.
Pruthvish S; Department of Community Medicine, M.S. Ramaiah Medical College, Bengaluru, Karnataka, India.
Prashanth R; Department of Public Health Dentistry, V S Dental College and Hospital, Bengaluru, Karnataka, India.; Pokaż więcej
Źródło:: Journal of cancer research and therapeutics [J Cancer Res Ther] 2023 Apr; Vol. 19 (Supplement), pp. S0.
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: Tobacco Use Cessation*
Smoking Cessation*
Female ; Humans ; Male ; Adult ; Middle Aged ; Nicotine/therapeutic use ; Follow-Up Studies ; Tobacco Use Cessation Devices ; Chronic Disease

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use.
Autorzy:: Pfarr KM; Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.
Krome AK; Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.; Department of Pharmaceutical Technology and Biopharmaceutics, University of Bonn, Bonn, Germany.
Al-Obaidi I; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
Batchelor H; Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
Vaillant M; Competence Center for Methodology and Statistics, Luxembourg Institute of Health, Strassen, Grand Duchy of Luxembourg.
Hoerauf A; Institute of Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.
Opoku NO; Department of Epidemiology and Biostatistics School of Public Health, University of Health and Allied Sciences, Hohoe, Ghana.
Kuesel AC; UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR), World Health Organization, Geneva, Switzerland. .; Pokaż więcej
Źródło:: Parasites & vectors [Parasit Vectors] 2023 Oct 31; Vol. 16 (1), pp. 394. Date of Electronic Publication: 2023 Oct 31.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Ivermectin*/therapeutic use
Anti-Infective Agents*/therapeutic use
Humans ; Rifampin ; Doxycycline ; Fluconazole ; Off-Label Use ; Drug Combinations ; Neglected Diseases/drug therapy ; Neglected Diseases/prevention & control

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Anti-Inflammatory and Immunomodulatory Effect of High-Dose Immunoglobulins in Children: From Approved Indications to Off-Label Use.
Autorzy:: Conti F; Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, 40138 Bologna, Italy.
Moratti M; Specialty School of Paediatrics, University of Bologna, 40138 Bologna, Italy.
Leonardi L; Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, 00185 Rome, Italy.
Catelli A; Specialty School of Paediatrics, University of Bologna, 40138 Bologna, Italy.
Bortolamedi E; Specialty School of Paediatrics, University of Bologna, 40138 Bologna, Italy.
Filice E; Department of Pediatrics, Maggiore Hospital, 40133 Bologna, Italy.
Fetta A; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, 40138 Bologna, Italy.; IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Neuropsichiatria dell'Età Pediatrica, 40139 Bologna, Italy.
Fabi M; Paediatric Emergency Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Facchini E; Pediatric Oncology and Hematology Unit 'Lalla Seràgnoli', IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Cantarini ME; Pediatric Oncology and Hematology Unit 'Lalla Seràgnoli', IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Miniaci A; Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Cordelli DM; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, 40138 Bologna, Italy.; IRCCS Istituto delle Scienze Neurologiche di Bologna, UOC Neuropsichiatria dell'Età Pediatrica, 40139 Bologna, Italy.
Lanari M; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, 40138 Bologna, Italy.; Paediatric Emergency Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
Pession A; Pediatric Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, 40138 Bologna, Italy.
Zama D; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, 40138 Bologna, Italy.; Paediatric Emergency Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.; Pokaż więcej
Źródło:: Cells [Cells] 2023 Oct 07; Vol. 12 (19). Date of Electronic Publication: 2023 Oct 07.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Off-Label Use*
Immunoglobulins, Intravenous*/therapeutic use
Humans ; Child ; Anti-Inflammatory Agents/therapeutic use ; SARS-CoV-2 ; Immunomodulation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Acceptance and Commitment Therapy-Based Smartphone Applications for Cessation of Tobacco Use among Adults with High Nicotine Dependence: Results from the iCanQuit Randomized Trial.
Autorzy:: Santiago-Torres M; Fred Hutchinson Cancer Center, Division of Public Health Sciences, Seattle, Washington, USA.
Mull KE; Fred Hutchinson Cancer Center, Division of Public Health Sciences, Seattle, Washington, USA.
Sullivan BM; Fred Hutchinson Cancer Center, Division of Public Health Sciences, Seattle, Washington, USA.
Rigotti NA; Tobacco Research and Treatment Center, Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Bricker JB; Fred Hutchinson Cancer Center, Division of Public Health Sciences, Seattle, Washington, USA.; Department of Psychology, University of Washington, Seattle, Washington, USA.; Pokaż więcej
Źródło:: Substance use & misuse [Subst Use Misuse] 2023; Vol. 58 (3), pp. 354-364. Date of Electronic Publication: 2023 Jan 23.
Typ publikacji:: Randomized Controlled Trial; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Tobacco Use Disorder*/therapy
Acceptance and Commitment Therapy*
Smoking Cessation*/methods
Electronic Nicotine Delivery Systems*
Adult ; Humans ; Nicotine ; Smartphone ; Tobacco Use Cessation Devices ; Tobacco Use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine and prevalence of molecular markers of anti-malarial drug resistance in children in Togo in 2021.
Autorzy:: Dorkenoo AM; Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo. .
Warsame M; School of Public Health and Community Medicine, University of Gothenburg, Gothenburg, Sweden.
Ataba E; Programme National de Lutte Contre le Paludisme, Lomé, Togo.
Hemou M; Service de Pédiatrie, Centre Hospitalier Universitaire Campus, Lomé, Togo.
Yakpa K; Programme National de Lutte Contre le Paludisme, Lomé, Togo.
Sossou E; Service des Laboratoires, Centre Hospitalier Universitaire Sylvanus Olympio Lomé, Lomé, Togo.
Mitigmsagou M; Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo.
Teou CD; Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo.
Caspar E; Institute of Parasitology and Tropical Diseases, Université de Strasbourg, UR7292 Dynamics of Host-Pathogen Interactions, 67000, Strasbourg, France.
Ma L; Biomics Platform, C2RT, Institut Pasteur, 75015, Paris, France.
Djadou KE; Faculté des Sciences de la Santé, Université de Lomé, Lomé, Togo.
Atcha-Oubou T; Programme National de Lutte Contre le Paludisme, Lomé, Togo.
Rasmussen C; Global Malaria Programme, World Health Organization, Geneva, Switzerland.
Menard D; Institute of Parasitology and Tropical Diseases, Université de Strasbourg, UR7292 Dynamics of Host-Pathogen Interactions, 67000, Strasbourg, France.; Malaria Genetics and Resistance Unit, Institut Pasteur, Université Paris Cité, INSERM U1201, 75015, Paris, France.; Malaria Parasite Biology and Vaccines, Institut Pasteur, Université Paris Cité, 75015, Paris, France.; Laboratory of Parasitology and Medical Mycology, CHU Strasbourg, 67000, Strasbourg, France.; Pokaż więcej
Źródło:: Malaria journal [Malar J] 2024 Apr 03; Vol. 23 (1), pp. 92. Date of Electronic Publication: 2024 Apr 03.
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: Antimalarials*/pharmacology
Antimalarials*/therapeutic use
Quinolines*/pharmacology
Quinolines*/therapeutic use
Malaria, Falciparum*/drug therapy
Malaria, Falciparum*/epidemiology
Malaria, Falciparum*/parasitology
Malaria*/drug therapy
Piperazines*
Artemisinins*
Child ; Adult ; Humans ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Artemether, Lumefantrine Drug Combination/pharmacology ; Prevalence ; Togo/epidemiology ; Prospective Studies ; Artemether/therapeutic use ; Drug Resistance ; Tetrahydrofolate Dehydrogenase/genetics ; Biomarkers ; Drug Combinations ; Plasmodium falciparum/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Association of anti-diabetic drugs and COVID-19 outcomes in patients with diabetes mellitus type 2 and cardiomyopathy.
Autorzy:: Dimnjaković J; Division for Health Informatics and Biostatistics, Croatian Institute of Public Health, Rockefeller's Street 7, 10 000, Zagreb, Croatia.
Buble T; Division for Health Informatics and Biostatistics, Croatian Institute of Public Health, Rockefeller's Street 7, 10 000, Zagreb, Croatia.
Ivanko P; Division for Health Informatics and Biostatistics, Croatian Institute of Public Health, Rockefeller's Street 7, 10 000, Zagreb, Croatia.
Pristaš I; Division for Health Informatics and Biostatistics, Croatian Institute of Public Health, Rockefeller's Street 7, 10 000, Zagreb, Croatia.
Brborović O; School of Medicine, Andrija Štampar School of Public Health, Department of Social Medicine and Health Care Organization, University of Zagreb, Rockefeller's Street 4, 10 000, Zagreb, Croatia. .
Brborović H; School of Medicine, Andrija Štampar School of Public Health, Department of Environmental and Occupational Health and Sports Medicine, University of Zagreb, Rockefeller's Street 4, 10 000, Zagreb, Croatia.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 27; Vol. 14 (1), pp. 7227. Date of Electronic Publication: 2024 Mar 27.
Typ publikacji:: Journal Article
MeSH Terms:: Dipeptidyl-Peptidase IV Inhibitors*/therapeutic use
COVID-19*/complications
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Cardiomyopathies*/chemically induced
Humans ; Hypoglycemic Agents/therapeutic use ; Retrospective Studies ; COVID-19 Vaccines/therapeutic use ; SARS-CoV-2 ; Sulfonylurea Compounds/therapeutic use ; Insulin/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Copayment mechanism in selected districts of Uganda: Availability, market share and price of quality assured artemisinin-based combination therapies in private drug outlets.
Autorzy:: Ocan M; Department of Pharmacology & Therapeutics, College of Health Sciences, Makerere University, Kampala, Uganda.
Nambatya W; Department of Clinical Pharmacy, College of Health Sciences, Makerere University, Kampala, Uganda.
Otike C; Data Department, Joint Clinical Research Centre, Lubowa, Kampala, Uganda.
Nakalembe L; Department of Pharmacology, Soroti University, Soroti, Uganda.
Nsobya S; Department of Pathology, College of Health Sciences, Makerere University, Kampala, Uganda.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 27; Vol. 19 (3), pp. e0295198. Date of Electronic Publication: 2024 Mar 27 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Antimalarials*/therapeutic use
Artemisinins*/therapeutic use
Malaria*/drug therapy
Humans ; Uganda ; Cross-Sectional Studies ; Artemether, Lumefantrine Drug Combination/therapeutic use ; Artemether/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Association of anti-diabetic drugs and covid-19 outcomes in patients with diabetes mellitus type 2 and chronic kidney disease: Nationwide registry analysis.
Autorzy:: Dimnjaković J; Division for Health Informatics and Biostatistics, Department for Biostatistics, Croatian Institute of Public Health, Zagreb, Croatia.
Buble T; Division for Health Informatics and Biostatistics, Department for Biostatistics, Croatian Institute of Public Health, Zagreb, Croatia.
Ivanko P; Division for Health Informatics and Biostatistics, Department for Biostatistics, Croatian Institute of Public Health, Zagreb, Croatia.
Poljičanin T; Health Center 'Dom zdravlja Zagreb zapad', Zagreb, Croatia.
Karanović Štambuk S; Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Centre Zagreb, Zagreb, Croatia.; Department of Internal Medicine, School of Medicine, University of Zagreb, Zagreb, Croatia.
Brborović H; Department of Environmental and Occupational Health and Sports Medicine, School of Medicine, University of Zagreb, Zagreb, Croatia.
Brborović O; Department of Social Medicine and Organization of Health Care, School of Medicine, University of Zagreb, Zagreb, Croatia.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 27; Vol. 19 (3), pp. e0301056. Date of Electronic Publication: 2024 Mar 27 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
COVID-19*/epidemiology
COVID-19*/complications
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Metformin*/therapeutic use
Renal Insufficiency, Chronic*/complications
Renal Insufficiency, Chronic*/epidemiology
Renal Insufficiency, Chronic*/drug therapy
Carbamates*
Piperidines*
Humans ; Retrospective Studies ; COVID-19 Vaccines/therapeutic use ; SARS-CoV-2 ; Hypoglycemic Agents/therapeutic use ; Sulfonylurea Compounds/therapeutic use ; Insulin/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: a pilot study.
Autorzy:: McKellar MS; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, P.O. Box 102359, Durham, NC, 27710, USA. .
Des Marais AC; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Chen H; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Choi Y; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Lilly R; North Carolina Harm Reduction Coalition, Wilmington, NC, USA.; Port City Harm Reduction, Wilmington, NC, USA.
Ayers D; Queen City Harm Reduction, Charlotte, NC, USA.
Bennett J; North Carolina Harm Reduction Coalition, Wilmington, NC, USA.
Kestner L; Queen City Harm Reduction, Charlotte, NC, USA.
Perry B; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Poley S; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Corneli A; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, P.O. Box 102359, Durham, NC, 27710, USA.; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.
Meade CS; Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.; Wake Forest University, Winston-Salem, NC, USA.
Sachdeva N; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA.; North Carolina Association of County Commissioners, Raleigh, NC, USA.; Pokaż więcej
Źródło:: Harm reduction journal [Harm Reduct J] 2024 Mar 26; Vol. 21 (1), pp. 69. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:: Clinical Trial; Journal Article
MeSH Terms:: Anti-HIV Agents*/therapeutic use
HIV Infections*/prevention & control
Opioid-Related Disorders*/drug therapy
Pre-Exposure Prophylaxis*
Substance Abuse, Intravenous*/drug therapy
Humans ; Male ; Buprenorphine, Naloxone Drug Combination/therapeutic use ; Pilot Projects ; Female

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Use"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji